Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Risk factors and effectiveness of preventive measures against influenza in the community.

Castilla J, Godoy P, Domínguez Á, Martín V, Delgado-Rodríguez M, Martínez-Baz I, Baricot M, Soldevila N, Mayoral JM, Astray J, Quintana JM, Cantón R, Castro A, González-Candelas F, Alonso J, Saez M, Tamames S, Pumarola T; CIBERESP Cases and Controls in Influenza Working Group..

Influenza Other Respir Viruses. 2013 Mar;7(2):177-83. doi: 10.1111/j.1750-2659.2012.00361.x. Epub 2012 Mar 27.

2.

Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.

Castilla J, Godoy P, Domínguez A, Martínez-Baz I, Astray J, Martín V, Delgado-Rodríguez M, Baricot M, Soldevila N, Mayoral JM, Quintana JM, Galán JC, Castro A, González-Candelas F, Garín O, Saez M, Tamames S, Pumarola T; CIBERESP Cases and Controls in Influenza Working Group Spain..

Clin Infect Dis. 2013 Jul;57(2):167-75. doi: 10.1093/cid/cit194. Epub 2013 Mar 26.

PMID:
23532475
3.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

4.

Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.

Steens A, Wijnans EG, Dieleman JP, Sturkenboom MC, van der Sande MA, van der Hoek W.

BMC Infect Dis. 2011 Jul 18;11:196. doi: 10.1186/1471-2334-11-196.

5.

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.

Martínez-Baz I, Martínez-Artola V, Reina G, Guevara M, Cenoz MG, Morán J, Irisarri F, Arriazu M, Albeniz E, Castilla J; Primary Health Care Sentinel Network of Navarre..

BMC Public Health. 2013 Mar 6;13:191. doi: 10.1186/1471-2458-13-191.

6.

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, Vanrell JM, Rodriguez C, Vega T, Martinez A, Torner N, Ramos JM, Serrano MC, Castilla J, Cenoz MG, Altzibar JM, Arteagoitia JM, Quiñones C, Perucha M, Larrauri A.

BMC Public Health. 2011 Nov 30;11:899. doi: 10.1186/1471-2458-11-899.

7.

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.

Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A; Primary Health Care Sentinel Network.; Network for Influenza Surveillance in Hospitals of Navarre..

Euro Surveill. 2013 Jan 31;18(5). pii: 20388.

8.

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.

Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, Larrauri A; cycEVA Study Team.; Spanish Influenza Sentinel Surveillance System..

Vaccine. 2012 May 21;30(24):3595-602. doi: 10.1016/j.vaccine.2012.03.048. Epub 2012 Mar 31.

PMID:
22472792
9.

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.

Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, Alvarez N, Arriazu M, Elía F, Salcedo E, Barricarte A; Primary Health Care Sentinel Network of Navarre..

Vaccine. 2011 Aug 11;29(35):5919-24. doi: 10.1016/j.vaccine.2011.06.063. Epub 2011 Jun 30.

PMID:
21723358
10.

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M.

Vaccine. 2011 Oct 19;29(45):7975-81. doi: 10.1016/j.vaccine.2011.08.068. Epub 2011 Aug 30.

PMID:
21884747
11.

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK; US Flu-VE Network..

Clin Infect Dis. 2012 Oct;55(7):951-9. Epub 2012 Jul 25.

12.

Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.

Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Martín V, Saez M, Soldevila N, Quintana JM, Mayoral JM, Astray J, González-Candelas F, Cantón R, Tamames S, Castro A, Baricot M, Alonso J, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain..

Vaccine. 2012 Aug 17;30(38):5644-50. Epub 2012 Jul 10.

PMID:
22796136
13.

Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness.

Ansaldi F, De Florentiis D, Parodi V, Rappazzo E, Coppelli M, Martini M, Alicino C, Durando P, Icardi G.

J Prev Med Hyg. 2012 Jun;53(2):94-7.

PMID:
23240167
14.

Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.

Savulescu C, Jiménez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, Larrauri A; cycEVA Study Team..

Euro Surveill. 2011 Mar 17;16(11). pii: 19820.

15.

[Pandemic influenza A (H1N1) virus infection factors among healthcare workers - a case-control study].

Deng Y, Zhang Y, Wang XL, Liu WT, Duan W, Yang P, Pang XH, Wang QY.

Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Dec;44(12):1075-8. Chinese.

PMID:
21215106
16.

Knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a low-income, public health clinic population.

Redelings MD, Piron J, Smith LV, Chan A, Heinzerling J, Sanchez KM, Bedair D, Ponce M, Kuo T.

Vaccine. 2012 Jan 5;30(2):454-8. doi: 10.1016/j.vaccine.2011.10.050. Epub 2011 Oct 30.

PMID:
22044740
17.

No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.

Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E.

Vaccine. 2011 Mar 21;29(14):2613-8. doi: 10.1016/j.vaccine.2011.01.046. Epub 2011 Feb 1.

PMID:
21292008
18.

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.

Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, Safont-Adsuara L, Ruiz-García M; Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain..

Vaccine. 2010 Nov 3;28(47):7460-7. doi: 10.1016/j.vaccine.2010.09.042. Epub 2010 Sep 25.

PMID:
20875486
19.

Influenza vaccine effectiveness in the community and the household.

Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS.

Clin Infect Dis. 2013 May;56(10):1363-9. doi: 10.1093/cid/cit060. Epub 2013 Feb 14.

20.

[A case-control study of an influenza A (H1N1) outbreak in a hospital].

Chen JD, Yuan J, He Z, Yang ZC, Wang M.

Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Feb;45(2):101-6. Chinese.

PMID:
21426786

Supplemental Content

Support Center